Abiopharma

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for its Alzheimer’s Disease Candidate INM-901

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease

Bausch Health Notification

Bausch Health Notification

Canopy Growth Communication - Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson